SAM
Sectoral Asset Management Portfolio holdings
AUM
$151M
This Quarter Return
+4.36%
1 Year Return
+14.02%
3 Year Return
+79.35%
5 Year Return
+153.48%
10 Year Return
+511.68%
AUM
$912M
AUM Growth
+$912M
(+14%)
Cap. Flow
+$98.3M
Cap. Flow
% of AUM
10.78%
Top 10 Holdings %
Top 10 Hldgs %
35.88%
Holding
80
New
13
Increased
28
Reduced
21
Closed
12
Top Buys
| 1 |
ARRY
Array Biopharma Inc
ARRY
|
$16.8M |
| 2 |
Gilead Sciences
GILD
|
$15.5M |
| 3 |
Exact Sciences
EXAS
|
$15.4M |
| 4 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
$12.5M |
| 5 |
Cogent Biosciences
COGT
|
$12M |
Top Sells
| 1 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$19.1M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
$14.8M |
| 3 |
LOXO
Loxo Oncology, Inc
LOXO
|
$12.8M |
| 4 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$12.3M |
| 5 |
AbbVie
ABBV
|
$8.25M |
Sector Composition
| 1 | Healthcare | 91.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Prothena Corp
PRTA
$452M
| – | – |
-184,063
| Closed | -$6.9M |
|
|
77
Regeneron Pharmaceuticals
REGN
$59.8B
| – | – |
-39,316
| Closed | -$14.8M |
|
|
KA
78
DELISTED
Kineta, Inc. Common Stock
KA
| – | – |
-300,000
| Closed | -$1.75M |
|
|
ONCE
79
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| – | – |
-83,390
| Closed | -$4.29M |
|
|
LOXO
80
DELISTED
Loxo Oncology, Inc
LOXO
| – | – |
-152,185
| Closed | -$12.8M |
|